UK failing to capitalise on disease research as it lags behind Europe, says ABPI

1 min


The UK is failing to capitalise on its world leading disease research, according to the country’s pharmaceutical body. The country could be unlocking significant economic benefits in better competing with its European rivals on genomics, the study of genomes which is crucial to understanding how diseases develop…
Read More


Like it? Share with your friends!

Send this to a friend